Switch from methadone to buprenorphine with microinduction in outpatient setting

Tidsskr Nor Laegeforen. 2024 Sep 5;144(10). doi: 10.4045/tidsskr.24.0073. Print 2024 Sep 10.
[Article in English, Norwegian]

Abstract

Background: Switching from methadone to buprenorphine in patients receiving opioid maintenance therapy often requires inpatient care with a gradual tapering of methadone and an opioid-free day with challenging withdrawal symptoms. This case report describes and discusses a gentle outpatient approach without the opioid-free day.

Case presentation: A patient with a 15-year history of opioid maintenance therapy reduced his methadone dose from 80 mg to 50 mg due to concurrent use of other sedative substances and a significant risk of overdose. A week-long switch to buprenorphine 16 mg subcutaneous depot formulation was then undertaken using a microinduction approach in the outpatient setting.

Interpretation: In line with earlier reports on microinduction, the switch from methadone to buprenorphine was carried out with no opioid withdrawal symptoms or complications. Microinduction offers a smooth and more patient-friendly approach to switching from full opioid agonists to partial agonists. Randomised controlled trials are, however, needed for a systematic evaluation of this method.

Publication types

  • Case Reports

MeSH terms

  • Ambulatory Care*
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / adverse effects
  • Buprenorphine* / administration & dosage
  • Buprenorphine* / therapeutic use
  • Delayed-Action Preparations
  • Humans
  • Male
  • Methadone* / administration & dosage
  • Methadone* / therapeutic use
  • Opiate Substitution Treatment* / methods
  • Opioid-Related Disorders* / drug therapy
  • Opioid-Related Disorders* / rehabilitation
  • Substance Withdrawal Syndrome / drug therapy

Substances

  • Buprenorphine
  • Methadone
  • Analgesics, Opioid
  • Delayed-Action Preparations